A Clinical Study Assessing the Efficacy of Chidamide for CD30-positive Peripheral T-cell Lymphoma (PTCL).
Clinical trial NCT06550336 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06550336
- Sponsor
- The First Hospital of Jilin University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-30
- Primary completion
- 2027-12-30
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.